Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05503524 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients

StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 2, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Dec 2023); last known: Not Yet Recruiting
  2. Primary completion date: Sep 2024 to Sep 2025 Start date: Sep 2023 to Sep 2024 · Completion date: Sep 2025 to Sep 2026v3 Show 2 more changesShow less
    • Start date: Sep 2023 to Sep 2024
    • Completion date: Sep 2025 to Sep 2026
  3. Primary completion date: Sep 10, 2023 to Sep 2024 Start date: Sep 10, 2022 to Sep 2023 · Completion date: Sep 10, 2024 to Sep 2025v2 Show 2 more changesShow less
    • Start date: Sep 10, 2022 to Sep 2023
    • Completion date: Sep 10, 2024 to Sep 2025
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Multiple Sclerosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Multiple Sclerosis patients.
Trial Details
NCT Number NCT05503524
Lead Sponsor Power Life Sciences Inc.
Conditions Multiple Sclerosis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov